Cargando…

The Innovative Medicines Initiative −10 Years of Public-Private Collaboration

The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. Born of the necessity to foster collaboration between different stakeholders in order to address growing challenges in bringing new medicines to market and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laverty, Hugh, Meulien, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902875/ https://www.ncbi.nlm.nih.gov/pubmed/31850354 http://dx.doi.org/10.3389/fmed.2019.00275

Ejemplares similares

Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare
por: de Vrueh, Remco L. A., et al.
Publicado: (2019)

A public–private collaboration model for clinical innovation
por: Wegner, Craig D., et al.
Publicado: (2022)

Boosting drug development through public-private partnerships – The IMI model
por: Laverty, Hugh
Publicado: (2014)

The Innovative Medicines Initiative: a Public Private Partnership Model to Foster Drug Discovery
por: Vaudano, Elisabetta
Publicado: (2013)

Public-private partnerships as driving forces in the quest for innovative medicines
por: Goldman, Michel, et al.
Publicado: (2013)

Scientific Advances in Diabetes: The Impact of the Innovative Medicines Initiative
por: Brito, Maria de Fátima, et al.
Publicado: (2021)

Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model
por: Bradshaw, Angela, et al.
Publicado: (2023)

Hypertension evaluated in the public and private Brazilian health system hypertension in public and private service
por: Amorim, Kecia C. F. O., et al.
Publicado: (2023)

Updates in SJS/TEN: collaboration, innovation, and community
por: Marks, Madeline E., et al.
Publicado: (2023)

Public–private partnerships in fostering outer space innovations
por: Rausser, Gordon, et al.
Publicado: (2023)

The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks
por: O'Rourke, Diana, et al.
Publicado: (2022)

Public–Private Partnerships in Cloud-Computing Services in the Context of Genomic Research
por: Granados Moreno, Palmira, et al.
Publicado: (2017)

Resolving shortages of prescription drugs: the case for public-private collaboration
por: Katz, Eric Efraim
Publicado: (2017)

Pharmaceutical Industry Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022)

Regulatory Authority Evaluation of the Effectiveness and Efficiency of the ZaZiBoNa Collaborative Medicines Registration Initiative: The Way Forward
por: Sithole, Tariro, et al.
Publicado: (2022)

The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery
por: Karawajczyk, Anna, et al.
Publicado: (2017)

More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?
por: Bubela, Tania, et al.
Publicado: (2017)

Nursing Homes: Affiliation to Large Chains, Quality and Public–Private Collaboration
por: Aguiar-Díaz, Inmaculada, et al.
Publicado: (2022)

Challenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine
por: Kraeber-Bodéré, Françoise, et al.
Publicado: (2014)

The Public Health Innovation Model: Merging Private Sector Processes with Public Health Strengths
por: Lister, Cameron, et al.
Publicado: (2017)

Long-term care: The public role and private initiatives
por: Burke, Thomas R.
Publicado: (1988)

Private and public values of innovation: A patent analysis of synthetic biology
por: Ribeiro, Barbara, et al.
Publicado: (2020)

The Assessment of the Innovativeness of a New Medicine in Italy
por: Fortinguerra, Filomena, et al.
Publicado: (2021)

Publication trends of artificial intelligence in retina in 10 years: Where do we stand?
por: Yang, Jingyuan, et al.
Publicado: (2022)

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US
por: Saxena, Kunal, et al.
Publicado: (2023)

Private–public collaboration in Iceland: battling COVID-19 with deCODE genetics
por: Olaf Sigurjonsson, Throstur, et al.
Publicado: (2022)

An evaluation tool to strengthen the collaborative process of the public-private partnership in the veterinary domain
por: Poupaud, Mariline, et al.
Publicado: (2021)

Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience
por: Bompart, François, et al.
Publicado: (2011)

From Opioid Pain Management to Opioid Crisis in the USA: How Can Public-Private Partnerships Help?
por: Bolliger, Larissa, et al.
Publicado: (2019)

Innovative Approaches to Increase Access to Medicines in Developing Countries
por: Stevens, Hilde, et al.
Publicado: (2017)

The Collaborative Governance Between Public and Private Companies to Address Climate Issues to Foster Environmental Performance: Do Environmental Innovation Resistance and Environmental Law Matter?
por: Sijing, Wei
Publicado: (2022)

Keratinoctye-neuro-immune-units (KNICUs): collaborative impact on the initiation and maintenance of psoriasis
por: Chen, Xue-Yan, et al.
Publicado: (2023)

The Private Partners of Public Health: Public-Private Alliances for Public Good
por: McDonnell, Sharon, et al.
Publicado: (2009)

Public–private partnerships in practice: collaborating to improve health finance policy in Ghana and Kenya
por: Suchman, Lauren, et al.
Publicado: (2018)

Public–private partnerships in practice: collaborating to improve health finance policy in Ghana and Kenya
por: Suchman, Lauren, et al.
Publicado: (2018)

The Medicine and Public Health Initiative: Ten Years Later
por: Beitsch, Leslie M., et al.
Publicado: (2005)

Regulatory policy and pharmaceutical innovation in the United Kingdom after Brexit: Initial insights
por: Hofer, Matthias P., et al.
Publicado: (2022)

Getting Digital Assets from Public–Private Partnership Research Projects through “The Valley of Death,” and Making Them Sustainable
por: Aartsen, Wendy, et al.
Publicado: (2018)

Collaborative public–private initiatives targeting multidrug-resistant tuberculosis (MDR-TB) supported by the Lilly MDR-TB Partnership: experiences in 2012–2016
por: Shelby, Peter W, et al.
Publicado: (2017)

Developing Reflection and Collaboration in Translational Medicine Toward Patients and Unmet Medical Needs
por: Clay, Moira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rf5q0qfm0h23lvu5emt0nhact2